This document summarizes anti-adrenergic or sympatholytic drugs. It discusses how these drugs block the actions of circulating catecholamines and inhibit effects of adrenergic nerve stimulation by antagonizing alpha-1 and alpha-2 receptors. It provides details on the types and mechanisms of various alpha-adrenergic antagonists including non-selective, alpha-1 selective, and alpha-2 selective drugs. The clinical uses of these drugs are in conditions like pheochromocytoma, hypertension, peripheral vascular disease, benign prostatic hyperplasia, and erectile dysfunction. Adverse effects include postural hypotension, tachycardia, and nasal congestion.
This document discusses psychotropic drugs and their implications for anesthesia. It begins by providing statistics on usage of antipsychotic drugs in India. It then classifies common psychotropic drugs like antipsychotics, antidepressants, mood stabilizers, and anxiolytics. The document discusses side effects and anesthetic implications of various drug classes like phenothiazines, SSRIs, lithium, and MAO inhibitors. It highlights risks like hypotension, arrhythmias, seizures, and drug interactions. The document emphasizes understanding psychopharmacology and manipulating drug levels to decrease perioperative morbidity.
This document discusses the role of anti-choline esterase drugs in the treatment of Alzheimer's disease. It defines Alzheimer's disease and describes its pathogenesis and neurochemistry. It then focuses on drugs used to treat cognitive symptoms, specifically anti-choline esterase drugs like donepezil, rivastigmine, and galantamine. These drugs inhibit the enzymes acetylcholinesterase and butyrylcholinesterase and are used as a maintenance treatment for mild to moderate Alzheimer's disease, with potential adverse effects like nausea, vomiting, and muscle cramps.
This document discusses inflammation and its role in musculoskeletal diseases. It describes how inflammation is normally a protective response but can become problematic. Several classes of anti-inflammatory drugs are explored, including NSAIDs like indomethacin, naproxen, and diclofenac. Their mechanisms of action, uses, and adverse effects are summarized. The document also covers hyperuricemia and gout, drugs like allopurinol used to treat it, and nursing considerations for these medications.
The document discusses several emergency drugs used in critical care including their indications, mechanisms of action, dosages, interactions and side effects. Atropine is used for bradycardia, bronchospasm and organophosphate poisoning. It works by blocking muscarinic receptors. Sodium nitroprusside is used for immediate blood pressure reduction and works by producing nitric oxide. Amiodarone is used for ventricular fibrillation and tachycardia, working on sodium, potassium and calcium channels. Aminophylline treats asthma exacerbations by bronchodilation and suppressing airway responses. Mannitol controls increased intracranial pressure through osmotic diuresis. Magnesium sulfate treats preeclampsia
Antipsychotics, chemistry and pharmacokineticsDomina Petric
1) Antipsychotic drugs can be categorized based on their chemical structure and include phenothiazines, butyrophenones, and atypical antipsychotics.
2) These drugs differ in their affinity for D2 and 5-HT2A receptors, with atypicals having a greater ability to alter 5-HT2A receptor activity.
3) Most antipsychotics are readily absorbed but undergo significant first-pass metabolism, distributed widely in tissues, and metabolized primarily in the liver by cytochrome P450 enzymes, resulting in potential drug-drug interactions.
The document discusses various pharmacological treatments for vertigo, including vestibular suppressants that reduce vertigo symptoms but also vestibular function, as well as anticholinergics, antihistamines, benzodiazepines, calcium channel blockers, and other drugs that modify neurotransmitter action in the vestibular system. Intratympanic therapies for conditions like Meniere's disease and gentamicin ablation of the vestibular system are also covered. Treatment depends on identifying the underlying pathomechanism through a detailed history, exam, tests and imaging.
This document discusses various types of psychosis and anti-psychotic drugs. It describes schizophrenia as a clinical syndrome characterized by profound cognitive and emotional disruption. Common anti-psychotic drugs are divided into typical and atypical classes. Typical drugs include phenothiazines and butyrophenones, while atypical drugs have different receptor binding profiles. Common side effects of anti-psychotics include extrapyramidal symptoms, metabolic issues, and tardive dyskinesia. Lithium is discussed as a treatment for bipolar disorder and mania through its effects on neurotransmitters and second messengers. Finally, antidepressants are outlined, including TCAs, SSRIs, and MAOIs, and their mechanisms of action
This document summarizes anti-adrenergic or sympatholytic drugs. It discusses how these drugs block the actions of circulating catecholamines and inhibit effects of adrenergic nerve stimulation by antagonizing alpha-1 and alpha-2 receptors. It provides details on the types and mechanisms of various alpha-adrenergic antagonists including non-selective, alpha-1 selective, and alpha-2 selective drugs. The clinical uses of these drugs are in conditions like pheochromocytoma, hypertension, peripheral vascular disease, benign prostatic hyperplasia, and erectile dysfunction. Adverse effects include postural hypotension, tachycardia, and nasal congestion.
This document discusses psychotropic drugs and their implications for anesthesia. It begins by providing statistics on usage of antipsychotic drugs in India. It then classifies common psychotropic drugs like antipsychotics, antidepressants, mood stabilizers, and anxiolytics. The document discusses side effects and anesthetic implications of various drug classes like phenothiazines, SSRIs, lithium, and MAO inhibitors. It highlights risks like hypotension, arrhythmias, seizures, and drug interactions. The document emphasizes understanding psychopharmacology and manipulating drug levels to decrease perioperative morbidity.
This document discusses the role of anti-choline esterase drugs in the treatment of Alzheimer's disease. It defines Alzheimer's disease and describes its pathogenesis and neurochemistry. It then focuses on drugs used to treat cognitive symptoms, specifically anti-choline esterase drugs like donepezil, rivastigmine, and galantamine. These drugs inhibit the enzymes acetylcholinesterase and butyrylcholinesterase and are used as a maintenance treatment for mild to moderate Alzheimer's disease, with potential adverse effects like nausea, vomiting, and muscle cramps.
This document discusses inflammation and its role in musculoskeletal diseases. It describes how inflammation is normally a protective response but can become problematic. Several classes of anti-inflammatory drugs are explored, including NSAIDs like indomethacin, naproxen, and diclofenac. Their mechanisms of action, uses, and adverse effects are summarized. The document also covers hyperuricemia and gout, drugs like allopurinol used to treat it, and nursing considerations for these medications.
The document discusses several emergency drugs used in critical care including their indications, mechanisms of action, dosages, interactions and side effects. Atropine is used for bradycardia, bronchospasm and organophosphate poisoning. It works by blocking muscarinic receptors. Sodium nitroprusside is used for immediate blood pressure reduction and works by producing nitric oxide. Amiodarone is used for ventricular fibrillation and tachycardia, working on sodium, potassium and calcium channels. Aminophylline treats asthma exacerbations by bronchodilation and suppressing airway responses. Mannitol controls increased intracranial pressure through osmotic diuresis. Magnesium sulfate treats preeclampsia
Antipsychotics, chemistry and pharmacokineticsDomina Petric
1) Antipsychotic drugs can be categorized based on their chemical structure and include phenothiazines, butyrophenones, and atypical antipsychotics.
2) These drugs differ in their affinity for D2 and 5-HT2A receptors, with atypicals having a greater ability to alter 5-HT2A receptor activity.
3) Most antipsychotics are readily absorbed but undergo significant first-pass metabolism, distributed widely in tissues, and metabolized primarily in the liver by cytochrome P450 enzymes, resulting in potential drug-drug interactions.
The document discusses various pharmacological treatments for vertigo, including vestibular suppressants that reduce vertigo symptoms but also vestibular function, as well as anticholinergics, antihistamines, benzodiazepines, calcium channel blockers, and other drugs that modify neurotransmitter action in the vestibular system. Intratympanic therapies for conditions like Meniere's disease and gentamicin ablation of the vestibular system are also covered. Treatment depends on identifying the underlying pathomechanism through a detailed history, exam, tests and imaging.
This document discusses various types of psychosis and anti-psychotic drugs. It describes schizophrenia as a clinical syndrome characterized by profound cognitive and emotional disruption. Common anti-psychotic drugs are divided into typical and atypical classes. Typical drugs include phenothiazines and butyrophenones, while atypical drugs have different receptor binding profiles. Common side effects of anti-psychotics include extrapyramidal symptoms, metabolic issues, and tardive dyskinesia. Lithium is discussed as a treatment for bipolar disorder and mania through its effects on neurotransmitters and second messengers. Finally, antidepressants are outlined, including TCAs, SSRIs, and MAOIs, and their mechanisms of action
Management of adverse effects of cancer chemotherapy 2Dr. Pooja
This document discusses the management of adverse effects from cancer chemotherapy. It describes common general side effects such as nausea, vomiting, myelosuppression and mucositis. Specific organ toxicities are also reviewed including liver veno-occlusive disease, hemorrhagic cystitis, nephrotoxicity, neurotoxicity, pulmonary toxicity, cardiotoxicity, hand foot syndrome and tumour lysis syndrome. For each toxicity, the causative agents, pathogenesis, clinical features, prevention and treatment strategies are discussed.
The document discusses various types of anti-psychotic drugs, including their classification, mechanisms of action, pharmacokinetics, clinical indications, and adverse effects. It focuses on drugs that block dopamine receptors in the brain to treat schizophrenia and other psychoses by modifying dopaminergic activity. The drugs discussed include both typical and atypical antipsychotics, as well as mood stabilizers like lithium that are used to treat bipolar disorder.
This document discusses pituitary gland disorders and anesthetic management. Key points include:
1. Pituitary tumors can cause hormonal imbalances and compression of surrounding structures, requiring careful perioperative management.
2. Patients may have hypopituitarism requiring steroid supplementation or acromegaly/Cushing's disease resulting in distinctive physical features and comorbidities.
3. Anesthesiologists must consider each patient's specific hormonal status and tumor effects when planning airway management and hemodynamic support for pituitary surgery.
Classical versus atypical antipsychoticsAkhil Joseph
This document summarizes key differences between typical and atypical antipsychotics. It discusses their mechanisms of action, efficacy, side effect profiles, pharmacokinetics, and drug interactions. Typical antipsychotics work mainly through D2 receptor antagonism and have higher rates of extrapyramidal side effects, while atypicals have additional 5-HT2A antagonism and generally cause more metabolic side effects like weight gain. Both classes present risks like QT prolongation, NMS, and low seizure thresholds that require monitoring.
Levodopa is the primary treatment for Parkinson's disease. It is converted to dopamine in the brain to increase dopamine levels and restore balance between inhibitory and excitatory neurons. Long term use can lead to motor fluctuations like wearing off effects and dyskinesia due to disease progression and pulsatile dopamine stimulation. Managing fluctuations involves adjusting dosage frequency and adding other drugs.
This document discusses parasympatholytics/anticholinergics like atropine. It describes their therapeutic classifications including mydriatics, antisecretory-antispasmodics, anti-Parkinsonian agents, anti-asthmatics, pre-anesthetics, and drugs for motion sickness and urinary incontinence. Atropine is discussed in depth, including its mechanism of action, pharmacological effects, therapeutic indications, differences from hyoscine, adverse effects and toxicity treatment. Contraindications of parasympatholytics are also listed.
Common withdrawal syndromes and managementSCGH ED CME
This document summarizes common withdrawal syndromes from alcohol, benzodiazepines, and opioids. It provides an overview of the pharmacology and pathophysiology of withdrawal from each substance and describes the typical signs and symptoms. For alcohol withdrawal, it outlines the stages of withdrawal and recommended pharmacological and non-pharmacological management. For benzodiazepine and opioid withdrawal, it discusses the receptor adaptations that occur with chronic use and contribute to withdrawal symptoms. It also notes recommended treatments which primarily involve tapering the offending agent or using other drugs like clonidine.
This document discusses contrast media used in radiology. It describes different types of contrast agents including iodinated, MR, and negative contrast agents. Iodinated contrast media can be ionic or non-ionic, and non-ionic agents have fewer adverse effects. Risk factors for contrast reaction include allergy, asthma, renal insufficiency, and cardiac issues. Reactions range from mild to severe and treatments involve medications like antihistamines, epinephrine, and IV fluids. Contrast-induced nephropathy is a deterioration of renal function caused by iodinated contrast and risk is highest in those with pre-existing severe renal insufficiency.
This document discusses antipsychotic and mood stabilizing drugs. It begins by classifying antipsychotics such as phenothiazines, butyrophenones, and atypical antipsychotics. It then describes the mechanism of action, uses, and adverse effects of typical antipsychotics like chlorpromazine and haloperidol. Atypical antipsychotics like clozapine and risperidone are also discussed. The document also covers mood stabilizers lithium and sodium valproate, focusing on lithium's mechanism and use in treating mania and bipolar disorder. Management of schizophrenia, mania, and bipolar disorder is described.
Thiopental is an ultra short-acting barbiturate that is commonly used for induction of anesthesia. It works by facilitating the inhibitory neurotransmitter GABA at GABAA receptors in the brain, causing sedation, hypnosis and general anesthesia. Thiopental has a rapid onset within 10-20 seconds after intravenous injection and its effects wear off within 5-15 minutes. It is highly soluble in water and stable in solution. Common uses include induction of anesthesia, treatment of increased intracranial pressure, and cerebral protection during certain surgeries. Side effects include respiratory depression, emergence delirium and prolonged recovery.
This document discusses the history and development of atypical antipsychotic medications. It begins with an overview of the serendipitous discoveries that led to the development of early antipsychotics like chlorpromazine in the 1950s. It then covers the development of second-generation atypical antipsychotics from the 1990s onward, including clozapine, risperidone, olanzapine, quetiapine, and others. The rest of the document details the mechanisms of action, therapeutic indications, side effect profiles, and dosing of various atypical antipsychotics.
To explain pathogenesis of Bipolar Disorders
To classify drugs used for treatment of Bipolar Disorders
To describe mechanism of action of drugs used for treatment of Bipolar Disorders
To enlist side effects of drugs used for treatment of Bipolar Disorders.
Indications: Bipolar, cyclothymia, schizoaffective, impulse control and intermittent explosive disorders.
Classes: Lithium, anticonvulsants, antipsychotics
Which you select depends on what you are treating and again the side effect profile.
Anticholinergic drugs act as competitive antagonists at muscarinic receptors. They block the effects of the neurotransmitter acetylcholine (Ach) and thus reduce parasympathetic nervous system activity. Key points:
- Atropine and scopolamine are examples of naturally occurring anticholinergic drugs. Synthetic muscarinic antagonists include benztropine, hyoscyamine, and oxybutynin.
- They have therapeutic effects in the eyes (mydriasis, cycloplegia), gastrointestinal tract (reducing motility), respiratory tract (reducing secretions), and central nervous system (treating extrapyramidal side effects).
- Potential adverse effects include dry
Parasympathomimetic or cholinergic drugs mimic the action of the stimulated parasympathetic nervous system. They are classified as direct-acting cholinergic agonists that directly bind to cholinergic receptors, or indirect-acting agonists that inhibit acetylcholinesterase to prolong the action of acetylcholine. Direct agonists like bethanechol are used to treat atonic bladder while indirect agonists like physostigmine and neostigmine are used to treat myasthenia gravis by blocking the antibodies that inhibit acetylcholine receptors. Myasthenia gravis is an autoimmune disorder where antibodies block acetylcholine receptors at the neuromuscular junction, weakening muscles.
This document provides an overview of antidepressant drugs. It discusses the criteria for major depression and epidemiology. It then covers the pharmacology of different classes of antidepressants including SSRIs, SNRIs, serotonin receptor antagonists, bupropion, and MAOIs. For each class, it discusses mechanisms of action, pharmacokinetics, uses, adverse effects, and drug interactions.
Schizophrenia is a complex psychiatric disorder characterized by disorganized thoughts, delusions, hallucinations, inappropriate affect, and impaired social functioning. The exact causes are unknown but likely involve genetic, brain chemical, environmental, and family history factors. Brain imaging shows enlarged ventricles and decreased cortical size, particularly in the left temporal lobe. Symptoms include positive symptoms like hallucinations, negative symptoms like loss of interest, and mood symptoms. Treatment involves pharmacological therapy with antipsychotics and non-pharmacological approaches like therapy, social skills training, and vocational rehabilitation.
This document discusses the vital and novel roles of anti-adrenergic drugs. It begins by introducing anti-adrenergic drugs and their mechanisms of action in inhibiting the neurotransmitters epinephrine and norepinephrine. The document then classifies adrenoceptors and discusses their functions and distribution. It categorizes anti-adrenergic drugs into alpha blockers, beta blockers, and mixed acting blockers. For each category, it provides examples, mechanisms of action, and vital roles in treating conditions like hypertension, heart failure, benign prostatic hyperplasia, prostate cancer, and more. In conclusion, the document states that anti-adrenergic drugs have wide therapeutic applications and can treat multiple
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
More Related Content
Similar to anaesthesia and psychotropic drugs.pptx
Management of adverse effects of cancer chemotherapy 2Dr. Pooja
This document discusses the management of adverse effects from cancer chemotherapy. It describes common general side effects such as nausea, vomiting, myelosuppression and mucositis. Specific organ toxicities are also reviewed including liver veno-occlusive disease, hemorrhagic cystitis, nephrotoxicity, neurotoxicity, pulmonary toxicity, cardiotoxicity, hand foot syndrome and tumour lysis syndrome. For each toxicity, the causative agents, pathogenesis, clinical features, prevention and treatment strategies are discussed.
The document discusses various types of anti-psychotic drugs, including their classification, mechanisms of action, pharmacokinetics, clinical indications, and adverse effects. It focuses on drugs that block dopamine receptors in the brain to treat schizophrenia and other psychoses by modifying dopaminergic activity. The drugs discussed include both typical and atypical antipsychotics, as well as mood stabilizers like lithium that are used to treat bipolar disorder.
This document discusses pituitary gland disorders and anesthetic management. Key points include:
1. Pituitary tumors can cause hormonal imbalances and compression of surrounding structures, requiring careful perioperative management.
2. Patients may have hypopituitarism requiring steroid supplementation or acromegaly/Cushing's disease resulting in distinctive physical features and comorbidities.
3. Anesthesiologists must consider each patient's specific hormonal status and tumor effects when planning airway management and hemodynamic support for pituitary surgery.
Classical versus atypical antipsychoticsAkhil Joseph
This document summarizes key differences between typical and atypical antipsychotics. It discusses their mechanisms of action, efficacy, side effect profiles, pharmacokinetics, and drug interactions. Typical antipsychotics work mainly through D2 receptor antagonism and have higher rates of extrapyramidal side effects, while atypicals have additional 5-HT2A antagonism and generally cause more metabolic side effects like weight gain. Both classes present risks like QT prolongation, NMS, and low seizure thresholds that require monitoring.
Levodopa is the primary treatment for Parkinson's disease. It is converted to dopamine in the brain to increase dopamine levels and restore balance between inhibitory and excitatory neurons. Long term use can lead to motor fluctuations like wearing off effects and dyskinesia due to disease progression and pulsatile dopamine stimulation. Managing fluctuations involves adjusting dosage frequency and adding other drugs.
This document discusses parasympatholytics/anticholinergics like atropine. It describes their therapeutic classifications including mydriatics, antisecretory-antispasmodics, anti-Parkinsonian agents, anti-asthmatics, pre-anesthetics, and drugs for motion sickness and urinary incontinence. Atropine is discussed in depth, including its mechanism of action, pharmacological effects, therapeutic indications, differences from hyoscine, adverse effects and toxicity treatment. Contraindications of parasympatholytics are also listed.
Common withdrawal syndromes and managementSCGH ED CME
This document summarizes common withdrawal syndromes from alcohol, benzodiazepines, and opioids. It provides an overview of the pharmacology and pathophysiology of withdrawal from each substance and describes the typical signs and symptoms. For alcohol withdrawal, it outlines the stages of withdrawal and recommended pharmacological and non-pharmacological management. For benzodiazepine and opioid withdrawal, it discusses the receptor adaptations that occur with chronic use and contribute to withdrawal symptoms. It also notes recommended treatments which primarily involve tapering the offending agent or using other drugs like clonidine.
This document discusses contrast media used in radiology. It describes different types of contrast agents including iodinated, MR, and negative contrast agents. Iodinated contrast media can be ionic or non-ionic, and non-ionic agents have fewer adverse effects. Risk factors for contrast reaction include allergy, asthma, renal insufficiency, and cardiac issues. Reactions range from mild to severe and treatments involve medications like antihistamines, epinephrine, and IV fluids. Contrast-induced nephropathy is a deterioration of renal function caused by iodinated contrast and risk is highest in those with pre-existing severe renal insufficiency.
This document discusses antipsychotic and mood stabilizing drugs. It begins by classifying antipsychotics such as phenothiazines, butyrophenones, and atypical antipsychotics. It then describes the mechanism of action, uses, and adverse effects of typical antipsychotics like chlorpromazine and haloperidol. Atypical antipsychotics like clozapine and risperidone are also discussed. The document also covers mood stabilizers lithium and sodium valproate, focusing on lithium's mechanism and use in treating mania and bipolar disorder. Management of schizophrenia, mania, and bipolar disorder is described.
Thiopental is an ultra short-acting barbiturate that is commonly used for induction of anesthesia. It works by facilitating the inhibitory neurotransmitter GABA at GABAA receptors in the brain, causing sedation, hypnosis and general anesthesia. Thiopental has a rapid onset within 10-20 seconds after intravenous injection and its effects wear off within 5-15 minutes. It is highly soluble in water and stable in solution. Common uses include induction of anesthesia, treatment of increased intracranial pressure, and cerebral protection during certain surgeries. Side effects include respiratory depression, emergence delirium and prolonged recovery.
This document discusses the history and development of atypical antipsychotic medications. It begins with an overview of the serendipitous discoveries that led to the development of early antipsychotics like chlorpromazine in the 1950s. It then covers the development of second-generation atypical antipsychotics from the 1990s onward, including clozapine, risperidone, olanzapine, quetiapine, and others. The rest of the document details the mechanisms of action, therapeutic indications, side effect profiles, and dosing of various atypical antipsychotics.
To explain pathogenesis of Bipolar Disorders
To classify drugs used for treatment of Bipolar Disorders
To describe mechanism of action of drugs used for treatment of Bipolar Disorders
To enlist side effects of drugs used for treatment of Bipolar Disorders.
Indications: Bipolar, cyclothymia, schizoaffective, impulse control and intermittent explosive disorders.
Classes: Lithium, anticonvulsants, antipsychotics
Which you select depends on what you are treating and again the side effect profile.
Anticholinergic drugs act as competitive antagonists at muscarinic receptors. They block the effects of the neurotransmitter acetylcholine (Ach) and thus reduce parasympathetic nervous system activity. Key points:
- Atropine and scopolamine are examples of naturally occurring anticholinergic drugs. Synthetic muscarinic antagonists include benztropine, hyoscyamine, and oxybutynin.
- They have therapeutic effects in the eyes (mydriasis, cycloplegia), gastrointestinal tract (reducing motility), respiratory tract (reducing secretions), and central nervous system (treating extrapyramidal side effects).
- Potential adverse effects include dry
Parasympathomimetic or cholinergic drugs mimic the action of the stimulated parasympathetic nervous system. They are classified as direct-acting cholinergic agonists that directly bind to cholinergic receptors, or indirect-acting agonists that inhibit acetylcholinesterase to prolong the action of acetylcholine. Direct agonists like bethanechol are used to treat atonic bladder while indirect agonists like physostigmine and neostigmine are used to treat myasthenia gravis by blocking the antibodies that inhibit acetylcholine receptors. Myasthenia gravis is an autoimmune disorder where antibodies block acetylcholine receptors at the neuromuscular junction, weakening muscles.
This document provides an overview of antidepressant drugs. It discusses the criteria for major depression and epidemiology. It then covers the pharmacology of different classes of antidepressants including SSRIs, SNRIs, serotonin receptor antagonists, bupropion, and MAOIs. For each class, it discusses mechanisms of action, pharmacokinetics, uses, adverse effects, and drug interactions.
Schizophrenia is a complex psychiatric disorder characterized by disorganized thoughts, delusions, hallucinations, inappropriate affect, and impaired social functioning. The exact causes are unknown but likely involve genetic, brain chemical, environmental, and family history factors. Brain imaging shows enlarged ventricles and decreased cortical size, particularly in the left temporal lobe. Symptoms include positive symptoms like hallucinations, negative symptoms like loss of interest, and mood symptoms. Treatment involves pharmacological therapy with antipsychotics and non-pharmacological approaches like therapy, social skills training, and vocational rehabilitation.
This document discusses the vital and novel roles of anti-adrenergic drugs. It begins by introducing anti-adrenergic drugs and their mechanisms of action in inhibiting the neurotransmitters epinephrine and norepinephrine. The document then classifies adrenoceptors and discusses their functions and distribution. It categorizes anti-adrenergic drugs into alpha blockers, beta blockers, and mixed acting blockers. For each category, it provides examples, mechanisms of action, and vital roles in treating conditions like hypertension, heart failure, benign prostatic hyperplasia, prostate cancer, and more. In conclusion, the document states that anti-adrenergic drugs have wide therapeutic applications and can treat multiple
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
Similar to anaesthesia and psychotropic drugs.pptx (20)
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
2. AIM OF THE TALK
• Basic PSYCHOPHARMACOLOGY in relation to ANAESTHESIA.
• Side effects of drugs relevant to ANAESTHESIA.
• Pharmacodynamics and pharmacokinetics in relation to ANAESTHESIA.
• Drug interatctions with ANAESTHETIC medications.
• Peri operative implications of PSYCHOTROPIC medications.
3. WHAT ARE PSYCHOTROPICS ???
LEGAL PSYCHOTROPICS
• ANTI ANXIETY AGENTS
• ANTI DEPRESSANTS
• ANTI PSYCHOTICS
• MOOD STABILIZERS
• STIMULANTS
ILLEGAL PSYCHOTROPICS
• COCAINE
• HEROIN
• LSD
• MARIJUANA
• AMPHETAMINES
ANY DRUG CAPABLE OF AFFECTING THE MIND, EMOTION AND BEHAVIOUR
OTHER PSYCHOTROPICS – ALCOHOL,NICOTINE, CAFFEINE,HERBAL MEDICINES.
4. BASIC MECHANISM OF ACTION OF ANTIDEPRESSANTS
THEY GENERALLY POTENTIATE THE ACTIONS OF NOREPINEPHRINE AND
SEROTONIN IN BRAIN EITHER DIRECTLY OR INDIRECTLY.
THE DRUGS INCLUDED ARE
1.TCAs 4. MAOIs
2.SSRIs 5. ATYPICAL ANTIDEPRESSANTS
3.SNRIs 6. HERBAL MEDICATIONS.
INHIBITION OF REUPTAKE
OF SEROTONIN,
NOREPINEPHRINE AT
PRESYNAPTIC TERIMINUS
INCREASED LEVELS OF
SEROTONIN AND
NOREPINEPHRINE AT
SYNAPTIC CLEFT
5. TRICYCLIC ANTIDEPRESSANTS (TCAs)
Inhibition of reuptake
of NE & 5HT
UNOPPOSED
CATECHOLAMINE
ACTION ON BRAIN
EXAGGERATED
RESPONSE TO
INDIRECT ACTING
VASOPRESSORS
ANTI CHOLINERGIC
SEDATION,DRYMOUTH,
CONSTIPATION
URINAY
RETENTION,BLURRY
VISION, DELIRIUM
ANTI MUSCARINIC
DIRECT
MYOCARDIAL
DEPRESSION,
ARRHYTHMIAS
PROLONGED QT
INTERVAL ,
WIDENED ECG
INTERVALS
ANTI ALPHA
ADRENOCEPTOR
POSTURAL
HYPOTENSION
SEDATION
EXAMPLES ARE AMITRYPTYLINE, NORTRYPTYLINE, IMIPRAMINE, DESIPRAMINE, DOTHIEPIN
6. PERIOPERATIVE CONCERNS OF TCAs
CAUTION IN PATIENTS
WITH PREXISTING
CARDIAC CONTIONS AND
ARRHYTHMIAS.
PREOPERATIVE ECG
AVOID MEPERIDINE,FENTANYL,
METHADONE,
ONDANSETRON,TRAMADOL,METACL
OPRAMIDE AS THEY PRECIPITATE
SEROTONIN SYNDROME
AVOID EPHEDRINE AND
METARAMINOL BECAUSE OF
THE EXAGGERATED RESPONSE
TO INDIRECT VASOPRESSORS
AVOID KETAMINE,
PANCURONIUM,
AND LAs
CONTAINING
EPINEPHRINE
BECAUSE OF
SYMPATHOMIMETIC
ACTION INCREASED MAC AND
ANAESTHETIC
REQUIREMENTS BECAUSE OF
ENHANCED BRAIN
CATECHOLAMINES
AVOID ATROPINE AND
SCOPALAMINE AS THEY
PRECIPITATE POST OPERATIVE
SEDATION AND DELIRIUM
ABRUPT
CESSATION MAY
CAUSE
CHOLINERGIC
REBOUND
WITHDRAWL
SYMPTOMS
PSYCHIATRIC PATIENT
ON TCAs COMING FOR
SURGERY
7. SSRIs AND SNRIs
SSRIs include
FLUOXETINE,SERTRALINE,PAROXETINE,FLUVOXAMINE,CITALOPRAM,ESCITALOPRAM
• SSRIs INHIBIT SEROTONIN REUPTAKE AND CYP-450 ENZYMES WITH MINIMAL ANTI CHOLINERGIC AND
SEDATIVE PROPERTIES
SNRIs INCLUDE DESVENLAFAXINE, DULOXETINE, MILNACIPRAN , LEVOMILNACIPRAN
• INHIBIT BOTH NOREPINEPHRINE AND SEROTONIN REUPTAKE AND CAUSE HYPERTENSION AS
PREDOMINANT SIDE EFFECT
8. PERIOPERATIVE CONCERNS OF SSRIs & SNRIs
PATIENT ON SSRI AND SNRI COMING FOR SURGERY
• ABNORMAL BLEEDING DUE TO
ALTERATION OF PLATELET SEROTONIN
LEVELS.
• POSSIBLE MECHNISMS FOR THIS IS
1. BLOCKADE OF PLATELET CALCIUM
2. NIRIC OXIDE SYNTHASE
INHIBITION
3. DECREASED PLATELET FACTORS
4. REDUCED PLATELET ACTIVATION
LEVELS OF
1.ANTI ARRHYTHMIC DRUGS
2.BENZODIAZEPINES
3.NEUROMUSCULAR BLOCKING
DRUGS
WILL BE PROLONGED BECAUSE OF
INHIBITION OF CYP 450 ENZYMES
SERTRALINE AND CITALOPRAM HAS LOWEST RISK OF BLEEDING WHEN COMBINED WITH WARFARIN
9.
10.
11.
12. MONO AMINE OXIDASE INHIBITORS(MAOIs)
MAOIs
INHIBIT OXIDATIVE
DEAMINATION OF
AMINES
INCREASE THE LEVELS OF
SERATONIN,NOREPINEPHRINE,
DOPAMAINE
MAOIs
IRREVERSIBLE NON SELECTIVE TYPE A
& TYPE B INHIBITORS
SELECTIVE REVERSIBLE
TYPE A INHIBITORS
PHNELIZINE,
TRANYLCYPROMINE,ISOCA
RBOXAZID
MOCLOBEMIDE
MAOIs ARE USED TO TREAT RESISTANT DEPRESSION
13. PERIOPERATIVE CONCERNs OF MAOIs
PATIENT ON MAOIs COMING
FOR SURGERY
HYPERTENSIVECRISIS.
AVOID TYRAMINE CONTAINING FOODS
LIKE CHEESE, FAVA BEANS, WINE ,
AVACADO
AVOID
PHENYLPROPONOLAMINE,
DEXTROMETHORPHAN,
PSEUDOEPHEDRINE.
RISK OF SYMPATHETIC
STIMULATION.
AVOID KETAMINE, MEPIRIDINE,
EPHEDRINE.
MAINTAIN GREATER DEPTH OF
ANAESTHESIA
NEEDS TO BE
CONTINUED
PERIOPERATIVELY
HYPOTENSION.
PHENYLEPHRINE IS
PREFERRED .
STRICT
MONITORING OF
BLOOD PRESSURE
RISK OF SEROTONIN
SYNDROME
PHENELIZINE- PLASMA
CHOLINESTERASE LEVELS. ACTION OF
SUCCYNYLCHOLINE AND
MIVACURIUM IS PROLONGED
MAC BECAUSE
OF INCREASED
CATECHOLAMINES
14. ATYPICAL
ANTIDEPRESSANTS SNRIs,NDRIs
SARIs
(serotonin antagonist and
receptor inhibitors)
CRIBs
(combined reuptake inhibitors
and receptor blockers)
BUPROPRION,TRAZADONE,
NEFZADONE,VENLAFAXINE
PERI OPERATIVE CONCERNS
ARE SIMILAR TO TCAs AND
MAOIs
NEFZADONE CAN CAUSE QT
PROLONGATION AND
INHIBITION OF CYP 450 3A4
ENZYME
16. HERBAL MEDICATIONS
St JOHNS WORT
PHARMACOLOGICAL
ACTIVITY IS BECAUSE OF
HYPERICIN AND
HYPERFORIN
ACTS BY INHIBITING REUPTAKE OF
SEROTONIN,NOREPINEPHRINE,
DOPAMINE
INDUCTION OF CYTOCHROME P450 ENZYMES;
EFFECTS LEVELS OF CYCLOSPORINE,WARFARIN,STEROIDS, BZDs, CCBs
DECREASED SERUM DIGOXIN LEVELS
DELAYED EMERGENCE
RECOMMONDED TO STOP 5 DAYS PRIOR TO SURGERY
17. HERBAL MEDICATIONS
VALERIAN
causes sedation
By GABA receptor
modulation
Increased sedative effects of anaesthetics
BZD like acute withdrawl
Increase anaesthetic requirements with
long term use
KAVA
Sedative and anxiolytic
because of
KAVALACTONES
Antiepileptic,neuroprotective,
local anaesthetic properties
Abuse potential
Increased gamma glutamyl
transpeptidase levels leads to
hepatotoxicity
Kava dermopathy
Recommonded
to stop 24 hrs
prior to surgery
18. HERBAL MEDICATIONS
GINGKO
Inhibit platelet
activating
factor
Pharmacological
effects are due to
flavanoids and
terpenoids
Increased risk of bleeding
Should be discontinued 36
hrs prior to surgery
GINSENG
Pharmacological
effects are due to
steroidal saponins
Inhibit platelet
aggregation
Hypoglycemia
Increased risk of
bleeding
Decrease the
anticoagulant
effect of warfarain
should be
discontinued 7
days prior to
surgery
19. ANTI PSYCHOTIC DRUGS (APDs)
TYPICAL APDs
• PREDOMINANTLY ACT BY
BLOCKING DOPAMINE (D2)
RECEPTORS
• HAVE EXTRA PYRAMIDAL SIDE
EFFECTS.
CHLORPROMAZINE
HALOPERIDOL
TRIFLUPERAZINE
ATYPICAL APDs
• PREDOMINANTLY BLOCKS
SEROTONIN(5HT2) RECEPTORS.
• ALSO BLOCK DOPAMINE, HISTAMINE,
MUSCARANIC AND ALPHA
ADRENERGIC RECEPTORS
• NO EXTRA PYRAMIDAL SIDE EFFECTS
CLOZAPINE,OLANZAPINE,RIS
PERIDONE,AMISUPIRIDE,
QUETIAPINE, ARIPIPRAZOLE
• PRIMARILY USED FOR TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDERS
• EFFECTIVE ONLY FOR TREATING ONLY POSITIVE SYMPTOMS OF SCHIZOPHRENIA
20. ANTI PSYCHOTIC DRUGS (APDs)
APDs
Block repolarising
potassium currents
Prolongs QT and
PR interval
Sudden cardiac
death
Neurolept malignant
syndrome
Mental state
changes
dysautonomia
Fever,rigidity
Idiosyncratic life
threatening
emergency
Orthostatic
hypotension
Anti cholinergic
side effects
Lowers seizure
threshold
21. ANTI PSYCHOTIC DRUGS (APDs)
PERI
OPERATIVE
CONCERNS
CONTINUED PERIOPERATIVELY
POTENTIATE
HYPOTENSIVE AND
SEDATIVE EFFECTS
OF GENERAL
ANAESTHETICS
TEMPARATURE REGULATION IS
IMPAIRED BECAUSE OF DOPAMINE
RECEPTOR BLOCKADE
HIGHER INCIDENCE
OF POSTOPERATIVE
ILEUS
• INCREASED RATES OF INFECTION BECAUSE OF IMMUNE SUPPRESSION
• WATER INTOXICATION DUE TO HYPERSECRETION OF ADH
22. LITHIUM
INORGANIC ION MAINLY USED FOR PROPHYLAXIS OF BIPOLAR DISORDER
MECHANISM OF ACTION
MIMICS SODIUM ION AT
MEMBRANES AND RESULTS IN
REDUCTION OF RELEASE OF
NEUROTRANSMITTERS
INHIBITING NMDA RECEPTOR
GSK3 INHIBITION AND
IONOSITOL DEPLETION
BY INHIBITING IMPase
NARROW THERAPEUTIC INDEX. SERUM LEVELS SHOULD BE MAINTAINED BETWEEN 0.6-1 mmol/l
SERUM LEVELS > 1.5 mmol/l ,TOXICITY OCCURS
CONFUSION, MUSCLE WEEKNESS,
TREMORS,SLURRED SPEECH
SA NODE DYSFUNCTION,AV BLOCK,
VENTRICULAR IRRITABILITY
HYPOTHYROIDISM
AS IT IS RENALLY EXCRETED, DEHYDRATION, DIURETICS, RENAL FAILURE INCREASE LITHIUM TOXICITY
23. LITHIUM
PERIOPERATIVE
CONCERNS
AVOID NSAIDS.
THEY INCREASE
LITHIUM LEVELS
BY 10-25%
AVOID THIAZIDE
DIURETICS. THEY
REDUCE RENAL
CLEARANCE OF LITHIUM
HAS TO BE STOPPED
72 HRS PRIOR TO
SURGERY
PROLONGS THE
ACTION OF BOTH
DEPOLARISING AND
NONDEPOLARISING
MUSCLE RELAXANTS
REDUCTION OF MAC
BECAUSE OF DECREASED
CATECHOLAMINE RELEASE
24. OTHER MOOD STABILISERS
CARBAMAZEPINE
Sodium channel blocker.
Treats MANIAC episodes
Induces cytochrome P450
system.
NMBs drugs should be given
more frequently.
Coagulopathy.
SODIUM VALPROATE
Enhances inhibitory effect
GABA
Highly protein bound.
Enhances the action of
other protein boiund drugs.
Thrombocytopenia
LAMOTRIGINE
Used to treat bipolar
depression.
Inhibits sodium and calcium
channels.
29. MALIGNANT
HYPERTHERMIA
PRECIPITATED BY
SUCCINYLCHOLINE AND
OTHER INHALATIONAL
AGENTS.
AUTOSOMAL DOMINANT
INHERITENCE.
HYPERCAPNIA,
TACHYPNOEA,
SYMPATHETIC NERVOUS
SYSTEM OVERACTIVATION
SEROTONIN
SYNDROME
PRECIPITATED BY
SEROTONERGIC DRUGS
(MAOIs,SSRIs,TCAs)
MYOCLONUS,
MYDRIASIS,
HYPERREFLEXIA,
HYPERACTIVE BOWEL
SOUNDS,
AGITATION
NEUROLEPT
MALIGNANT
SYNDROME
PRECIPITATED BY
ANTIPSYCHOTICS.
ABRUPT CESSATION OF
DOPAMINERGIC DRUGS
CHOREA,
OPISTHOTONUS,
TRISMUS,
BLEPHAROSPASM,
OCCULOGYRIC CRISIS
30. ALCOHOL
ACUTE INTOXICATION
• Respiratory depresssion,
coma
• Risk of aspiration.
Intubation for airway
protection and furthur
management
CHRONIC ALCOHOL MISUSE
• Examination should concentrate on
• CVS-(hypertension, arrhythmias, and signs
of cardiac failure)
• CNS- (disturbance of vision, co-ordination or
cognitive function, or evidence of autonomic
or peripheral neuropathies).
• Specific signs of liver disease should also be
sought
Before surgery, administration of parenteral B vitamins may be indicated to prevent
Wernicke –Korsakoff syndrome.
Vitamin K, clotting factors, fresh frozen plasma, or platelets may also be necessary to
correct coagulopathy.
31.
32. PERIOPERATIVE CONCERNS OF ALCOHOL
REGIONAL ANAESTHESIA
• Any pre existing neurlogical deficit or
neuropathy should be documented.
• Sudden severe hypotension can
occur in patients who are on
treatment with Disulfuram
• Hypotension can be treated with
phenylephrine (preferable) and
Ephedrine.
• Neuropathy sometimes considered
as medicolegal contraindication
GENERAL ANAESTHESIA
• Rapid sequence induction
• Increase requirements of anaesthetic
agents because of cytochrome P450
enzyme induction
• The effective doses of propofol,
thiopental, and opioids such as alfentanil
are increased.
• The distribution and metabolism of
anaesthetic drugs is altered by
hypoalbuminaemia and hepatic
impairment.
• Alcohol use is an independent risk factor
for post operative delirium.
33. ALCOHOL WITHDRAWL SYNDROME
The syndrome results from neurological receptor changes after long-term alcohol use.
Ethanol binds to post-synaptic GABAA receptors, enhancing their inhibitory effect.
The resulting chronic excitatory suppression, coupled with a direct inhibition of excitatory
glutamate N-methyl-D-aspartate (NMDA) receptors, leads to an increased brain synthesis of
excitatory neurotransmitters such as norepinephrine, 5hydroxytryptamine, and dopamine.
When the inhibitory effects of ethanol are withdrawn, the brain becomes exposed to
increased levels of excitatory neurotransmitters
34. Alcohol withdrawal syndrome is characterized by
Tremor,
Gastric upset,
Sweating,
Hypertension,
Hyper-reflexia,
Anxiety,
Agitation progressing to delirium, hallucinations,
and seizures.
35. COCAINE
Cocaine produces prolonged adrenergic stimulation by blocking the presynaptic uptake
of sympathomimetic neurotransmitters including norepinephrine, serotonin, and
dopamine
GENERAL ANAESTHESIA
• Ketamine should be used with
extreme caution- enhances cvs
toxicity
• Action of suxamethonium is
prolonged.
• Increased volatile anaesthetic
requirement in acute intoxication
• Hyperthermia and sympathomimetic
effects mimick malignant
hyperthermia
REGIONAL ANAESTHESIA
• Combative Behavior
• Altered pain perception
• Cocaine – induced Thrombocytopenia
• Ephedrine - resistant hypotension
ESMOLOL is the preferred
beta blocker
36. MARIJUANA
PERI OPERATIVE
CONCERNS
primary psychoactive
constituent is
tetrahydrocannabinol (THC)
Causes increased SNS
activity and decreases para
sympathetic nervous system
activity.
Anaesthesia
during acute
exposure is
preferably avoided
Additive effects of
marijuana and inhaled
anaesthetics will result
in severe myocardial
depression
Ketamine,atropine,
ephedrine , pancuronium
should be avoided
Intra operative bronchospasm
can occur due to airway
irritability by marijuana smoke
Enhace the
sedative and
hypnotic effects of
CNS depressants.
37.
38. Real case scenario
• 38 YEAR FEMALE POSTED FOR ROBOTIC HYSTERECTOMY
• Has h/o hypothyroidism on thyronorm 25 mcg
• Has history of Paranoid schizophrenia on aripiprazole 5mg OD For the past 5 years.
• H/o 2 suicide attempts in the past
• h/o admission to psychiatric hospital 2 times
• No other comorbidities
39.
40. REFERENCES
• Anesthetic Considerations for Patients on Psychotropic Drug Therapies
Monica W. Harbell 1,* Catalina Dumitrascu 1, Layne Bettini 1, Soojie Yu 1, Cameron M. Thiele 2 and
Veerandra Koyyalamudi 1 NEUROLOGY INTERNATIONAL
• Anaesthetic Implications of Substance Abuse in Adolescent A Rudra1, Anjan Bhattacharya2, S Chatterjee3,
S Sengupta4, T Das INDIAN JOURNAL OF ANAESTHESIA
• Tom Peck, BSc MBBS FRCA, Adrian Wong, BSc (Hons) MBBS MRCP, Emma Norman, BSc (Hons) MBBS,
Anaesthetic implications of psychoactive drugs, Continuing Education in Anaesthesia Critical Care & Pain,
Volume 10, Issue 6, December 2010, Pages 177–181, BRITISH JOURNAL OF ANAESTHESIA
• MILLERS TEXT BOOK OF ANAESTHESIA 9TH EDITION
• ANAESTHESIA AND PSYCHIATRIC DRUGS –PART 2 MOOD STABILISERS AND ANTIPSYCHOTICS ANAESTHESIA
TUTORIAL OF THE WEEK 175
• ANAESTHESIA & PSYCHIATRIC DRUGS part 1 –ANTIDEPRESSANTS ANAESTHESIA TUTORIAL OF THE WEEK
164 14th DECEMBER 2009